Abstract
The objective of this study is to determine the effects of adrenomedullin (AM) on IL-1- and TNF-α-induced rheumatoid synovial fibroblasts (RASFs)-mediated osteoclastogenesis. The formation of osteoclasts in co-cultures of RASFs and peripheral blood mononuclear cells was evaluated by tartrate-resistant acid phosphatase and resorption pit formation assay. The expression of RANKL, OPG, p-ERK, p-p38, and p-JNK was examined by immunoblotting and quantitative reverse transcription-polymerase chain reaction. AM (1-52) inhibits IL-1- and TNF-α-induced RASFs-mediated osteoclastogenesis. AM affected IL-1-, TNF-α-induced RANKL and OPG expression in RASFs. AM also inhibits IL-1 and TNF-α-induced phosphorylation of ERK-1/2, p38 MAPK, and JNK. Inhibitor of AM (AM 22-52) inhibits the effects of AM on the osteoclastogenesis. These results suggest that AM might be involved in the inflammatory cytokines-mediated osteoclastogenesis and thus bone damage, and indicate that it can be a new therapeutic strategy against joint destruction in RA.
Similar content being viewed by others
References
Cawston TE (1995) Proteinase and connective tissue breakdown. In: Henderson B, Edwards JCW, Pettipher ER (eds) Mechanisms and models in rheumatoid arthritis. Academic Press, London
Han MK, Kim JS, Park BH et al (2003) NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: potential role in rheumatoid arthritis. J Leukoc Biol 73:525–529
Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR (1998) Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943–951
Lee HY, Jeon HS, Song EK et al (2006) CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis. Arthritis Rheum 54:1747–1758
Kong YY, Yoshida H, Sarosi I et al (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315–323
Goldring SR (2002) Bone and joint destruction in rheumatoid arthritis: what is really happening? J Rheumatol Suppl 65:44–48
Romas E, Gillespie MT, Martin TJ (2002) Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30:340–346
Matsushita T, Matsui N, Yoshiya S, Fujioka H, Kurosaka M (2004) Production of adrenomedullin from synovial cells in rheumatoid arthritis patients. Rheumatol Int 24:20–24
Chosa E, Hamada H, Kitamura K, Eto T, Tajima N (2003) Increased plasma and joint tissue adrenomedullin concentrations in patients with rheumatoid arthritis compared to those with osteoarthritis. J Rheumatol 30:2553–2556
Gonzalez-Rey E, Chorny A, O’Valle F, Delgado M (2007) Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells. Am J Pathol 170:263–271
Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Mbalaviele G, Nishimura R, Myoi A et al (1998) Cadherin-6 mediates the heterotypic interaction between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of osteoclast differentiation. J Cell Biol 141:1467–1476
Nanke Y, Kotake S, Yonemoto K, Saito S, Tomatsu T, Kamatani N (2003) Adrenomedullin in synovial fluids from patients with rheumatoid arthritis inhibits interleukin 6 production from synoviocytes. Ann Rheum Dis 62:82–83
Han Z, Boyle DL, Chang L et al (2001) c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108:73–81
Badger AM, Griswold DE, Kapadia R et al (2000) Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum 43:175–183
Nishikawa M, Myoui A, Tomita T, Takahi K, Nampei A, Yoshikawa H (2003) Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis Rheum 48:2670–2681
McLatchie LM, Fraser NJ, Main MJ et al (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333–339
Kobayashi K, Takahashi N, Jimi E et al (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275–285
Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ (2002) TNF potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143:1108–1118
Uzan B, Ea HK, Launay JM et al (2006) A critical role for adrenomedullin-calcitonin receptor-like receptor in regulating rheumatoid fibroblast-like synoviocyte apoptosis. J Immunol 176:5548–5558
Nagaya N, Satoh T, Nishikimi T et al (2000) Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 101:498–503
Genovese MC, Kremer JM (2004) Treatment of rheumatoid arthritis with etanercept. Rheum Dis Clin North Am 30(2):311–328
Caramaschi P, Biasi D, Colombatti M et al (2006) Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol Int 26(3):209–214
Acknowledgments
“The work was supported by Korea Research Foundation Grant (KRF-2007-314-E00111) and the Fund of Chonbuk National University Hospital Research Institute of Clinical Medicine.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yun, HJ., Lee, EG., Lee, SI. et al. Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-α. Rheumatol Int 29, 1161–1168 (2009). https://doi.org/10.1007/s00296-008-0832-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-008-0832-0